Autologous or Syngeneic Stem Cell Transplant
Showing 1 - 25 of >10,000
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Based on Maintenance Therapy Post Autologous Stem Cell
Recruiting
- Multiple Myeloma
- Autologous Stem Cell Transplant
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jul 27, 2022
Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)
Not yet recruiting
- Multiple Myeloma
- Iberdomide
- Daratumumab/rHuPH20 Co-formulation
- (no location specified)
Oct 25, 2023
Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)
Active, not recruiting
- Multiple Myeloma
- Auto Stem Cell Transplant
-
Hackensack, New JerseyJohn Theurer Cancer Center @ Hackensack University Medical Cente
Dec 23, 2022
Multiple Myeloma Trial in Salt Lake City (Budesonide EC, Placebo)
Not yet recruiting
- Multiple Myeloma
- Budesonide EC
- Placebo
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Jan 9, 2023
Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)
Recruiting
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma
- Etoposide
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 25, 2023
Morbidity, Long-term Side Effects and Quality of Life in
Recruiting
- Germ Cell Tumor
-
Villejuif, FranceGustave Roussy
Jun 2, 2023
Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)
Active, not recruiting
- Plasma Cell Leukemia
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)
Not yet recruiting
- Multiple Myeloma
- Stem Cell Transplant Complications
- PARE
- Waitlist Control Group
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 30, 2023
T-Cell Lymphoma Trial in Saint Louis (Duvelisib, Peripheral blood draw)
Recruiting
- T-Cell Lymphoma
- Duvelisib
- Peripheral blood draw
-
Saint Louis, MissouriWashington University School of Medicine
Jul 18, 2022
Multiple Myeloma Trial in Hackensack (Thalidomide+Melphalan +Bortezomib+stem cell transplant)
Completed
- Multiple Myeloma
- Thalidomide+Melphalan +Bortezomib+stem cell transplant
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Dec 16, 2022
T Cell Lymphoma Trial in Kansas City (Brentuximab Vedotin)
Withdrawn
- T Cell Lymphoma
- Brentuximab Vedotin
-
Kansas City, KansasThe University of Kansas Cancer Center, Westwood Campus
Feb 1, 2023
AL Amyloidosis Trial (procedure, drug, other)
Not yet recruiting
- AL Amyloidosis
- Autologous Hematopoietic Stem Cell Transplantation
- +15 more
- (no location specified)
Aug 28, 2023
Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)
Not yet recruiting
- Acute Leukemia
- Rifaximin with allogeneic stem cell transplant
- Allogeneic stem cell transplant
- (no location specified)
Sep 21, 2023
Myeloma Trial in Philadelphia (Belantamab mafodotin)
Recruiting
- Myeloma
- Belantamab mafodotin
-
Philadelphia, PennsylvaniaAbramson Cancer Center at University of Pennsylvania
Jun 13, 2022
Systemic Lupus Erythematosus, Systemic Sclerosis Trial in Philadelphia (Depletion of CD3/CD19 in an autologous stem cell
Recruiting
- Systemic Lupus Erythematosus
- Systemic Sclerosis
- Depletion of CD3/CD19 in an autologous stem cell transplant
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
May 23, 2022
Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)
Active, not recruiting
- Plasma Cell Leukemia
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)
Not yet recruiting
- Lymphoma
- Peripheral Blood Stem Cell Transplantation
- Eltrombopag olamine
- (no location specified)
Jul 25, 2023
Preparation of Patient Autologous Induced Pluripotent Stem
Not yet recruiting
- Age-Related Macular Degeneration
- somatic cell collection
- (no location specified)
Aug 14, 2023
Multiple Myeloma Trial in Birmingham (Multi-modal Exercise Regimen, Dietary Guidelines)
Not yet recruiting
- Multiple Myeloma
- Multi-modal Exercise Regimen
- Dietary Guidelines
-
Birmingham, AlabamaKirklin Clinic of UAB Hospital
Nov 29, 2022
Autologous Stem Cell Transplant Trial in Edmonton (Airvo)
Not yet recruiting
- Autologous Stem Cell Transplant
- Airvo
-
Edmonton, Alberta, CanadaCross Cancer Institute
Apr 28, 2022
Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)
Completed
- Non-Hodgkin's Lymphoma
- Plasma Cell Myeloma
- Hematopoietic Cell Transplantation
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022
Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)
Recruiting
- Haploidentical Hematopoietic Stem Cell Transplantation
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 11, 2023
Well-being of Caregivers (Caregiver Strain Index) Trial in Durham (home care)
Recruiting
- Well-being of Caregivers (Caregiver Strain Index)
- home care
-
Durham, North CarolinaDuke University Medical Center
Jan 25, 2023